Table 4.
PSMA-FGS in PCa patients.
| Year | Stage | Country | Institution | Excitation/emission | NCT# | Agents | Patient number | Patient Type | FGS type |
|---|---|---|---|---|---|---|---|---|---|
| 202315 | Phase 2a | Netherlands | Leiden University Medical Center, Leiden University, Leiden | 774/— nm | European Trial Database, 2019-002393-31; | OTL78 | 18 | Primary PCa with ISUP≥7 | RP±ePLND (da Vinci surgical system) |
| 202316 | Phase I | USA | University of California, San Francisco | 774/793 nm | NCT04574401 | IS-002 | 24 | High-risk primary prostate cancer | RP+ePLND (da Vinci surgical system) |